Literature DB >> 16750209

Evaluation of reproductive potential after intracytoplasmic sperm injection of varied human semen tested by antiacrosomal antibodies.

Olina Tepla1, Jana Peknicova, Karel Koci, Josef Mika, Milan Mrazek, Fatima Elzeinova.   

Abstract

OBJECTIVE: To determine whether varied human spermatozoa, as detected with monoclonal antibodies against acrosomal proteins, have an influence on fertilization, transfer, pregnancy, and implantation rates when intracytoplasmic sperm injection is used.
DESIGN: A retrospective study.
SETTING: A private IVF center and academic research laboratory. PATIENT(S): One thousand two hundred forty men participating in the intracytoplasmic sperm injection program. INTERVENTION(S): Sperm were divided into seven groups: oligozoospermia, oligoasthenozoospermia, and oligoasthenoteratozoospermia and fresh and frozen-thawed epididymal and fresh and frozen-thawed testicular sperm. Fertilization, transfer, pregnancy, and implantation rates were recorded in each category. Sperm were tested with antibodies for detection of the of the sperm acrosome. MAIN OUTCOME MEASURE(S): Fertilization, transfer, pregnancy and implantation rates, and percentage of acrosome-reacted cells. RESULT(S): The fertilization rate and statistical evaluation showed differences between morphologically normal and pathological sperm and other groups. The freezing-thawing procedure had no influence on the fertilization of testicular sperm, but epididymal frozen-thawed sperm had a higher fertilization rate. Immunofluorescence proved decreasing sperm quality in all groups compared with the control group. This difference is not manifested in other parameters (transfer, pregnancy, implantation rates). CONCLUSION(S): The spermatozoa with varied semen characteristics and good quality, also detected with specific antibodies, gave the best fertilization rates. The paternal effect is not proved in other parameters.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16750209     DOI: 10.1016/j.fertnstert.2005.12.019

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

1.  Different sperm sources and parameters can influence intracytoplasmic sperm injection outcomes before embryo implantation.

Authors:  Yue-hong Lu; Hui-juan Gao; Bai-jia Li; Ying-ming Zheng; Ying-hui Ye; Yu-li Qian; Chen-ming Xu; He-feng Huang; Fan Jin
Journal:  J Zhejiang Univ Sci B       Date:  2012-01       Impact factor: 3.066

2.  Characterization and possible function of glyceraldehyde-3-phosphate dehydrogenase-spermatogenic protein GAPDHS in mammalian sperm.

Authors:  Hasmik Margaryan; Andriy Dorosh; Jana Capkova; Pavla Manaskova-Postlerova; Anatoly Philimonenko; Pavel Hozak; Jana Peknicova
Journal:  Reprod Biol Endocrinol       Date:  2015-03-08       Impact factor: 5.211

3.  Evaluation of the expression of sperm proteins in normozoospermic and asthenozoospermic men using monoclonal antibodies.

Authors:  Jana Capkova; Alena Kubatova; Lukas Ded; Olina Tepla; Jana Peknicova
Journal:  Asian J Androl       Date:  2016 Jan-Feb       Impact factor: 3.285

4.  The Transgenerational Transmission of the Paternal Type 2 Diabetes-Induced Subfertility Phenotype.

Authors:  Eva Zatecka; Romana Bohuslavova; Eliska Valaskova; Hasmik Margaryan; Fatima Elzeinova; Alena Kubatova; Simona Hylmarova; Jana Peknicova; Gabriela Pavlinkova
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-05       Impact factor: 5.555

5.  Expression analysis of MND1/GAJ, SPATA22, GAPDHS and ACR genes in testicular biopsies from non-obstructive azoospermia (NOA) patients.

Authors:  Andriy Dorosh; Olina Tepla; Eva Zatecka; Lukas Ded; Karel Koci; Jana Peknicova
Journal:  Reprod Biol Endocrinol       Date:  2013-05-15       Impact factor: 5.211

6.  Target antigens for Hs-14 monoclonal antibody and their various expression in normozoospermic and asthenozoospermic men.

Authors:  Jana Capkova; Hasmik Margaryan; Alena Kubatova; Petr Novak; Jana Peknicova
Journal:  Basic Clin Androl       Date:  2015-11-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.